Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicity

被引:5
作者
Kano, K
Yamada, Y
Shiraiwa, T
Shimizu, A
Nishikura, K
Arisaka, O
Tomita, S
Ueda, Y
机构
[1] Dokkyo Univ, Sch Med, Dept Pediat, Shimotsuga, Tochigi 3210293, Japan
[2] Dokkyo Univ, Sch Med, Dept Surg & Mol Pathol, Shimotsuga, Tochigi 3210293, Japan
[3] Dokkyo Univ, Sch Med, Dept Pathol, Koshigaya Hosp, Shimotsuga, Tochigi 3210293, Japan
关键词
bone fracture; child; cyclosporine; epidural lipomatosis; nephrotic syndrome; prednisolone;
D O I
10.1111/j.1440-1797.2004.00341.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoid treatment for steroid-dependent nephrotic syndrome (NS) is associated with severe adverse effects, such as bone fractures and epidural lipomatosis. Furthermore, a high trough level of cyclosporine (CsA) over an extended period of time is known to induce CsA nephropathy. We present a girl with steroid-dependent NS and steroid-induced vertebral compression fractures and epidural lipomatosis who was treated with a high-dose of prednisolone after experiencing several relapses. A high CsA trough level (between 147 and 225 ng/mL) over a period of only 5 months was effective in improving the vertebral compression fractures, alleviating the epidural lipomatosis by enabling the discontinuation of prednisolone treatment. Thus, high trough levels of CsA over a short period of time may enable prednisolone to be discontinued in cases of steroid-dependent NS without causing any clinical, histological, serum and/or urinary CsA-related adverse effects.
引用
收藏
页码:414 / 417
页数:4
相关论文
共 50 条
  • [41] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
    Gilbert, Rodney D.
    Hulse, Eleanor
    Rigden, Susan
    PEDIATRIC NEPHROLOGY, 2006, 21 (11) : 1698 - 1700
  • [42] Predictors of frequent relapsing and steroid-dependent nephrotic syndrome in children
    Dakshayani, B.
    Lakshmanna, Manjula
    Premalatha, R.
    TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, 2018, 53 (01): : 24 - 30
  • [43] Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome
    Kawasaki, Y
    Suzuki, J
    Takahashi, A
    Isome, M
    Nozawa, R
    Suzuki, H
    PEDIATRIC NEPHROLOGY, 2005, 20 (01) : 96 - 98
  • [44] Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome
    Afzal, Kamran
    Bagga, Arvind
    Menon, Shina
    Hari, Pankaj
    Jordan, Stanley C.
    PEDIATRIC NEPHROLOGY, 2007, 22 (12) : 2059 - 2065
  • [45] STEROID-DEPENDENT NEPHROTIC SYNDROME FOLLOWING RENAL-TRANSPLANTATION FOR CONGENITAL NEPHROTIC SYNDROME
    LANE, PH
    SCHNAPER, HW
    VERNIER, RL
    BUNCHMAN, TE
    PEDIATRIC NEPHROLOGY, 1991, 5 (03) : 300 - 303
  • [46] Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children
    Dossier, Claire
    Bonneric, Stephanie
    Baudouin, Veronique
    Kwon, Theresa
    Prim, Benjamin
    Cambier, Alexandra
    Couderc, Anne
    Moreau, Christelle
    Deschenes, Georges
    Hogan, Julien
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (12): : 1555 - 1562
  • [47] Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome
    Ohtomo, Y
    Fujinaga, SI
    Hattori, M
    PEDIATRICS INTERNATIONAL, 2005, 47 (02) : 230 - 231
  • [48] Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration
    Shuichiro Fujinaga
    Daishi Hirano
    Naoto Nishizaki
    Tomonosuke Someya
    Yoshiyuki Ohtomo
    Yoshikazu Ohtsuka
    Toshiaki Shimizu
    Kazunari Kaneko
    Pediatric Nephrology, 2011, 26 : 479 - 483
  • [49] Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome
    S. Mendizábal
    I. Zamora
    O. Berbel
    M. J. Sanahuja
    J. Fuentes
    J. Simon
    Pediatric Nephrology, 2005, 20 : 914 - 919
  • [50] Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome
    Mendizábal, S
    Zamora, I
    Berbel, O
    Sanahuja, MJ
    Fuentes, J
    Simon, J
    PEDIATRIC NEPHROLOGY, 2005, 20 (07) : 914 - 919